Search for: "Health Industries v. European Health Spas" Results 1 - 15 of 15
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Sep 2022, 4:15 pm by INFORRM
A recent criminal case against a former health adviser found guilty of illegally accessing patient records illustrates when the ICO can make an application to the sentencing court for compensation, forcing the offender to pay money to data subject victims. [read post]
30 May 2021, 4:07 pm by INFORRM
On the same day Tipples J heard an application in the case of Mincione v GEDI Gruppo Editoriale SpA. [read post]
7 Aug 2019, 12:43 am
PatentsIn Takeda v Roche: "Is it plausible? [read post]
26 May 2019, 2:13 pm
Trade marksGuestKat Nedim Malovic takes a look at a decision of EUIPO first Board of Appeal concerning the relevant public’s perception of the polysemic term SPA, which, on the one hand, is the designation of the Belgian town Spa, where there is also a health spa, well-known to the Belgian public; on the other hand, it is also the common name that designates a spa-facility (a hydrotherapy facility). [read post]
14 Mar 2017, 6:01 pm by Bill Marler
In a memo to FDA, the committee states: “the sixty-day aging process for hard cheese is questionable as an effective measure in support of the public’s health. [read post]
29 Jul 2016, 8:06 am by Bill Marler
In a memo to FDA, the committee states: “the sixty-day aging process for hard cheese is questionable as an effective measure in support of the public’s health. [read post]
19 Sep 2013, 8:34 pm by Bill Marler
In a memo to FDA, the committee states: “the sixty-day aging process for hard cheese is questionable as an effective measure in support of the public’s health. [read post]
7 Feb 2011, 2:58 am by Marie Louise
– Superintendent of Industry and Commerce signs agreement with Spanish PTO (IP tango) Does a non-registered licensee have ‘locus standi’? [read post]
6 Feb 2011, 1:59 am
In a memo to FDA, the committee states: "the sixty-day aging process for hard cheese is questionable as an effective measure in support of the public's health. [read post]
13 Oct 2008, 12:12 pm
(IPKat) German Federal Supreme Court (Bundesgerichtshof) guidance regarding registrability of 'spa' in relation to beauty care products and spa services (Class 46)   Europe ARMAFOAM: the ECJ rules on linguistic and changes OHIM's rules on conversion: Armacell v OHIM (CATCH US IF YOU CAN !!!) [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog)   Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris:… [read post]
16 May 2008, 8:03 am
, 20-21 May: US ACI ‘In-house counsel forum on pharmaceutical antitrust’ – Maryland: (Orange Book Blog), 26-27 May : EU Workshop for mediators in IP disputes – Geneva: (IPR-Helpdesk), 27 May: Oliver Rivers to give short talk on ‘spurious precision’ – London: (IP finance), 28 May / 11June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – New… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]
23 Dec 2007, 8:00 pm
: (IPKat),Spare part design protection: the European Parliament's view: (IPKat), (Catch us if you can)Cyprus fails to delight Turkey -  Cyprus is to gain PGI recognition for Turkish delight: (IPKat),Mewsings on the word ‘technical' (What does the EPO mean when it uses the word ‘technical'?) [read post]